Outsourcing STREAM
-
The Path Forward, Altasciences' Approach To Project Management
3/19/2024
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
-
Ensuring Reliable Clinical Trial Material Production
8/27/2024
As an integrated CRO/CDMO, Altasciences combines formulation and pharmacy expertise to optimize drug products, support clinical trials, and help resolve challenges that could impact development timelines.
-
Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments
5/5/2023
Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.
-
We Are Altasciences: Proactive Drug Development
1/30/2023
When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.
-
Imagine⦠Easier, Proactive Drug Development
2/14/2023
Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.
-
Early Phase Clinical Development Solutions
1/30/2023
Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.
-
RTSM Software Isn't One-Size-Fits-All, Especially For Small Biotechs
5/13/2026
Smaller biotech companies often have very different clinical trial needs than large pharmaceutical organizations, and that includes RTSM.
-
The Heart Of The Matter: Early Vs. Late QT Prolongation Testing
2/8/2023
Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.
-
Getting Buy-In For Disclosure As A Service
6/3/2020
Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.
-
How To Take Advantage Of Early Access Programs For The EU
6/12/2024
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.